Low dose oral pharmaceutical composition of pirfenidone or salt thereof
AssigneeZenvision Pharma LLP
InventorsSivakumar Venkata Bobba, Bhimrao Jadhav, Dhananjay Shinde, Sunil Pophale
Life of this patent
Estimating the term…
Abstract
The present invention relates to Suprabioavailable oral composition of Pirfenidone or salt thereof when compared with reference product of Pirfenidone capsule [267 mg] and tablet [267 mg and 801 mg] for the treatment of idiopathic pulmonary fibrosis (IPF). The Suprabioavailable oral composition of Pirfenidone or salt thereof provides at least 5% dose reduction which minimizes adverse effects and provides more efficacy with better patient compliance in the treatment of idiopathic pulmonary fibrosis.
Claims15
A Suprabioavailable pharmaceutical composition comprising Pirfenidone or salt thereof;
- when compared with reference product capsule of 267 mg & tablet of 267 mg and 801 mg.
Dependencies are inferred from the claim text.